[Protective effect of berberine on cardiac hypertrophy induced by L-thyroxine in rats].
To assess the effects of berberine on cardiac hypertrophy induceded by L-thyroxine(L-Thy) in rats. A cardiac hypertrophy model was produced by intraperitoneal (i.p.) injection of L-thyroxine 0.5 mg/(kg.d) x 10 d. 24 SD rats were divided into three groups: 1. control (normal saline); 2. L-Thy; 3. i.p. L-Thy + berberine gastrogavage 30 mg/(kg.d) x 10 d. Then the cardiac indexes, Na(+)-K(+)-ATPase activity, Ca(2+)-ATPase activity, the cardiac nitric oxide (NO) content, and the CaN activity were measured. Compared with the measurements in the control group, the cardiac indexes and the CaN activity were remarkably increased in the hypertrophy group (P < 0.01), but the cardiac NO content, Na(+)-K(+)-ATPase activity and Ca(2+)-ATPase activity in myocardium were significantly decreased (P < 0.01). Further comparison between the hypertrophy group and the L-Thy + berberine group showed that berberine 30 mg/(kg.d) x 10 d prevented the ventricular hypertrophy induced by L-Thy and decreased the cardiac indexes and CaN activity (P < 0.01); berberine elevated the cardiac NO content, Na(+)-K(+)-ATPase activity and Ca(2+)-ATPase activity (P < 0.01). Berberine can prevent the cardiac hypertrophy induced by L-thyroxine in rats.